| Product Code: ETC7745240 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Performance Enhancing Drugs Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Performance Enhancing Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Performance Enhancing Drugs Market - Industry Life Cycle |
3.4 Japan Performance Enhancing Drugs Market - Porter's Five Forces |
3.5 Japan Performance Enhancing Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Performance Enhancing Drugs Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.7 Japan Performance Enhancing Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Performance Enhancing Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of performance-enhancing drugs in sports and fitness industries |
4.2.2 Growing demand for sports nutrition and supplements in Japan |
4.2.3 Rise in the number of individuals participating in competitive sports and fitness activities |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies governing the use of performance-enhancing drugs in Japan |
4.3.2 Negative publicity and ethical concerns surrounding the use of such drugs in sports |
4.3.3 Health risks and potential side effects associated with performance-enhancing drugs |
5 Japan Performance Enhancing Drugs Market Trends |
6 Japan Performance Enhancing Drugs Market, By Types |
6.1 Japan Performance Enhancing Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Performance Enhancing Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Performance Enhancing Drugs Market Revenues & Volume, By Ergogenic Aids, 2021- 2031F |
6.1.4 Japan Performance Enhancing Drugs Market Revenues & Volume, By Nootropic, 2021- 2031F |
6.1.5 Japan Performance Enhancing Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Performance Enhancing Drugs Market, By Products |
6.2.1 Overview and Analysis |
6.2.2 Japan Performance Enhancing Drugs Market Revenues & Volume, By Pills, 2021- 2031F |
6.2.3 Japan Performance Enhancing Drugs Market Revenues & Volume, By Injections, 2021- 2031F |
6.2.4 Japan Performance Enhancing Drugs Market Revenues & Volume, By Patches, 2021- 2031F |
6.2.5 Japan Performance Enhancing Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Performance Enhancing Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Performance Enhancing Drugs Market Revenues & Volume, By Athletes, 2021- 2031F |
6.3.3 Japan Performance Enhancing Drugs Market Revenues & Volume, By Body Builders, 2021- 2031F |
6.3.4 Japan Performance Enhancing Drugs Market Revenues & Volume, By Students, 2021- 2031F |
6.3.5 Japan Performance Enhancing Drugs Market Revenues & Volume, By Militaries, 2021- 2031F |
6.3.6 Japan Performance Enhancing Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Performance Enhancing Drugs Market Import-Export Trade Statistics |
7.1 Japan Performance Enhancing Drugs Market Export to Major Countries |
7.2 Japan Performance Enhancing Drugs Market Imports from Major Countries |
8 Japan Performance Enhancing Drugs Market Key Performance Indicators |
8.1 Percentage increase in the number of gym memberships or sports club enrollments |
8.2 Number of sports events or competitions held in Japan |
8.3 Growth in demand for sports-specific nutritional supplements |
8.4 Percentage change in the number of athletes testing positive for banned substances |
9 Japan Performance Enhancing Drugs Market - Opportunity Assessment |
9.1 Japan Performance Enhancing Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Performance Enhancing Drugs Market Opportunity Assessment, By Products, 2021 & 2031F |
9.3 Japan Performance Enhancing Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Performance Enhancing Drugs Market - Competitive Landscape |
10.1 Japan Performance Enhancing Drugs Market Revenue Share, By Companies, 2024 |
10.2 Japan Performance Enhancing Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |